Column

Clinical Pathways GPS

The New FDA and Its Impact on Clinical Pathways

06/14/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...

...

06/14/2017

Journal of Clinical Pathways

Editor's Page

Clinical Pathways: Local, National, and International

06/14/2017

Winston Wong , PharmD;

If you are an oncologist, you are probably picking up this month’s edition of Journal of Clinical Pathways as you return from the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Given the...

If you...

06/14/2017

Journal of Clinical Pathways

Pharma Insights

What Does New Payer Research on Expected Biosimilar Management Mean to Others?

05/12/2017

Larry Blandford , PharmD;

Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...

...

05/12/2017

Journal of Clinical Pathways

Clinical Pathways GPS

The Next 1361 Days and How They Will Impact Clinical Pathways

05/12/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...

Over...

05/12/2017

Journal of Clinical Pathways

Editor's Page

No Summer Vacation for Clinical Pathways

05/12/2017

Winston Wong , PharmD;

Summer is a time for rest and relaxation, a chance to recharge after long and stressful winters. However, for medical professionals—particularly oncologists—the beginning of June is one of the more hectic times of...

Summer...

05/12/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Preparing for Take-Off: Readying Older Adults for Flight

04/11/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Sevy Gambs , MBA, ALA, MSN-GR;

Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...

Older...

04/11/2017

Journal of Clinical Pathways

Pharma Insights

The Clash: Treatment Advances and Value Measurements in Oncology

04/11/2017

Jason Shafrin , PhD;

Larry Blandford , PharmD;

Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention strategies...

Cancer...

04/11/2017

Journal of Clinical Pathways

Editor's Page

Clinical Pathways and Access to Quality Care

04/11/2017

Winston Wong , PharmD;

Patients are entitled to the best possible health care at the lowest possible cost. Clinical pathways have served to promote evidence-based medicine and value-based care across the medical continuum. The quality of...

...

04/11/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Developing Balanced Clinical Pathways Through Individualized Care

03/15/2017

Terri L. Schieder , RN, MS, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Clinical pathways should address all three aspects of the Triple Aim, but the aim of improving population health often is prioritized at the expense of improving the patient experience of care and reducing the cost...

...

03/15/2017

Journal of Clinical Pathways

Pharma Insights

The Role of Payers in Antibiotic Stewardship: Facilitating Transitions of Care for Patients With Active Infection

03/15/2017

Jeremy Schafer , PharmD, MBA;

All members of the health care community must play a role in antimicrobial stewardship. The payer role is to monitor appropriate antibiotic use, encourage low-cost options, and help to facilitate the transition of...

All...

03/15/2017

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products